Navigation Links
HTG-Ventrex, Signalife's Contract Manufacturer, Acquired by Parker Hannifin Corporation
Date:4/28/2008

GREENVILLE, S.C., April 28 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) announced today that its contract manufacturer, Ventrex Inc., Ventura, CA, acquired by the Hi-Tech Group in September 2007, has been acquired by Parker Hannifin Corporation (NYSE: PH), Cleveland, OH as part of the Parker Hannifin strategic entry into the medical device manufacturing industry. The Hi-Tech Group, a 2007 Medical Design Excellence Award winner, combines the strength of Ventrex with other engineering, molding, assembly and plastics companies expanding its technical service offering to Signalife and the medical device industry. Signalife is pleased to have chosen Ventrex, Inc., a highly responsive and capable full service medical device contract manufacturer with ISO 13485 certification and FDA registration, as its contract manufacturer. With a broad array of process capabilities, foremost attention to quality, total responsiveness, and highly efficient operation, Ventrex offers superior value in medical device contract manufacturing services.

Dr. Budimir S. Drakulic, Signalife's Chief Technology Officer commented: "This acquisition is very important for Signalife's manufacturing capabilities. We have a great business relationship with HTG-Ventrex and are glad that they are now part of Medical Systems Division of Parker's Seal Group. Ventrex, Hi-Tech, and now Parker Hannifin remain totally committed to Signalife and its product's success."

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices, therapies and/or technologies that simplify and reduce the costs of cardiovascular disease.

Signalife, Inc. is traded on the American Stock Exchange under the symbol SGN. More information is located at http://www.signalife.com. Clear Data. Trusted Results.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state or governmental or international regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain import and export capabilities in the various countries containing buyers and resellers and hospitals and clinics and doctors for the Signalife devices, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vystar Corporation and Revertex Malaysia Sign Vytex(TM) NRL Production Contract
2. Contract signed for ESAs Sentinel-3 Earth observation satellite
3. Pennsylvania Contractor Pleads Guilty to Participating in Fraud Conspiracy at New York Presbyterian Hospital
4. SAIC Awarded $16 Million Contract by General Services Administration
5. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
6. SAIC Awarded DIA Intelligence Analysis Contract
7. BurgessGroup Announces Contract Renewal and Software Upgrade by CalOptima
8. eq-life(R) and Fairview Pharmacy Services Announce Multi-Year Consulting Contract with Alegent Health
9. Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract
10. UC RNs Overwhelmingly Approve New Contract
11. RxElite Awarded Anesthetic Gases Multi-Source Contract by Premier Inc., a Purchasing Network for More than 1,500 U.S. Hospitals and 49,000 Other Healthcare Sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: